Latest filing published 23 Aug 2024 for Adaptive Biotechnologies Corp, €109k.
Filing timeline
BuySaleInsider track record
Stacy L. Taylor: trading record in brief
Stacy L. Taylor (senior executive) discloses dealings in Adaptive Biotechnologies Corp to SEC (Form 4). We count 85 filings; the first trade dates from 8 January 2020 and the latest from 22 August 2024.
Sales make up the whole of the open-market record (41 sales, €4.1M). Besides market trades, the filings include 4 share grants and 40 option exercises. 2024 to date brings no purchases and 3 sales.
Most recently, on 23 August 2024, the filings show an open-market sale worth €109k in Adaptive Biotechnologies Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stacy L. Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,922 shares@ US$4.497450.4% of flowCommon StockSEC:0001062993-24-015606:0
- 39,990 shares0Common StockSEC:0001062993-24-005766:0
- 6,772 shares@ US$3.430.4% of flowCommon StockSEC:0001062993-24-005766:1
- 6,609 shares@ US$3.440.4% of flowCommon StockSEC:0001062993-24-005766:2
- 85,697 shares0Common StockSEC:0001062993-23-006328:0
- 5,491 shares@ US$8.570.9% of flowCommon StockSEC:0001062993-23-006328:1
- 13,387 shares@ US$8.602.1% of flowCommon StockSEC:0001062993-23-006328:2
- 2,387 shares@ US$11.4411.6% of flowCommon StockSEC:0001209191-22-018095:0
- 1,569 shares@ US$12.010.3% of flowCommon StockSEC:0001209191-22-017397:1
- 61,779 shares0Common StockSEC:0001209191-22-017397:0
- 5,208 shares@ US$7.800.7% of flowCommon StockSEC:0001209191-21-071194:1
- 15,338 shares@ US$30.008.2% of flowCommon StockSEC:0001209191-21-071194:2
- 10,130 shares@ US$6.5527.2% of flowCommon StockSEC:0001209191-21-071194:0
- 495 shares@ US$40.000.3% of flowCommon StockSEC:0001209191-21-055367:1
- 495 shares@ US$6.551.3% of flowCommon StockSEC:0001209191-21-055367:0
- 1,771 shares@ US$6.550.2% of flowCommon StockSEC:0001209191-21-044630:1
- 1,354 shares@ US$31.710.7% of flowCommon StockSEC:0001209191-21-044630:2
- 3,772 shares@ US$41.352.7% of flowCommon StockSEC:0001209191-21-044630:3
- 395 shares@ US$42.130.3% of flowCommon StockSEC:0001209191-21-044630:4
- 1,042 shares@ US$7.803.2% of flowCommon StockSEC:0001209191-21-044630:0
- 1,771 shares@ US$6.550.2% of flowCommon StockSEC:0001209191-21-042291:1
- 1,354 shares@ US$31.710.7% of flowCommon StockSEC:0001209191-21-042291:2
- 4,166 shares@ US$40.002.8% of flowCommon StockSEC:0001209191-21-042291:3
- 1,041 shares@ US$7.803.2% of flowCommon StockSEC:0001209191-21-042291:0
- 1,770 shares@ US$6.550.2% of flowCommon StockSEC:0001209191-21-029626:1
25 of 83 declarations
